Mapping the Synaptome in Neurodegeneration: Emerging Clinical Applications of SV2A PET Imaging
Although the field remains limited by small cohorts, heterogeneous quantification strategies, and incomplete longitudinal validation, SV2A PET is rapidly evolving into a promising translational tool for studying synaptopathies and monitoring disease progression.